Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-Labeled, Multi-Center Study to Investigate the Safety and Efficacy of OROS Hydromorphone HCl Comparing With Morphine SR in Cancer Pain Patients

NCT00803283 is registered in ClinicalTrials.gov with Johnson & Johnson Taiwan Ltd as lead sponsor.

NCT NCT00803283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00803283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-Labeled, Multi-Center Study to Investigate the Safety and Efficacy of OROS Hydromorphone HCl Comparing With Morphine SR in Cancer Pain Patients
Lead sponsor
Johnson & Johnson Taiwan Ltd
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 2008
Completion date
December 31, 2008
Enrollment
2 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer pain